DK0775745T3 - Cathepsin G-inhiberende aptamerer - Google Patents

Cathepsin G-inhiberende aptamerer

Info

Publication number
DK0775745T3
DK0775745T3 DK96118661T DK96118661T DK0775745T3 DK 0775745 T3 DK0775745 T3 DK 0775745T3 DK 96118661 T DK96118661 T DK 96118661T DK 96118661 T DK96118661 T DK 96118661T DK 0775745 T3 DK0775745 T3 DK 0775745T3
Authority
DK
Denmark
Prior art keywords
cathepsin
aptamers
inhibitory aptamers
nucleotides
inhibitory
Prior art date
Application number
DK96118661T
Other languages
English (en)
Inventor
Franzpeter Bracht
Karsten Prof Dr Med Schroer
Original Assignee
Gentium Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentium Spa filed Critical Gentium Spa
Application granted granted Critical
Publication of DK0775745T3 publication Critical patent/DK0775745T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
DK96118661T 1995-11-24 1996-11-21 Cathepsin G-inhiberende aptamerer DK0775745T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19543750A DE19543750C2 (de) 1995-11-24 1995-11-24 Cathepsin G inhibierende Aptamere

Publications (1)

Publication Number Publication Date
DK0775745T3 true DK0775745T3 (da) 2004-06-01

Family

ID=7778263

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96118661T DK0775745T3 (da) 1995-11-24 1996-11-21 Cathepsin G-inhiberende aptamerer

Country Status (8)

Country Link
US (1) US5780449A (da)
EP (1) EP0775745B1 (da)
JP (1) JP4257939B2 (da)
AT (1) ATE258597T1 (da)
DE (2) DE19543750C2 (da)
DK (1) DK0775745T3 (da)
ES (1) ES2217297T3 (da)
PT (1) PT775745E (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682886B1 (en) * 1994-04-28 2004-01-27 Gilead Sciences, Inc. Bivalent binding molecules of 7 transmembrane G protein-coupled receptors
WO1999050462A1 (en) * 1998-03-27 1999-10-07 President And Fellows Of Harvard College Aptamer based bacterial inhibition systems (abbis)
US6458559B1 (en) 1998-04-22 2002-10-01 Cornell Research Foundation, Inc. Multivalent RNA aptamers and their expression in multicellular organisms
DE19916417A1 (de) * 1999-04-01 2000-10-19 Schering Ag Amyloidspezifisches Aptamer
AU9630501A (en) * 2000-09-26 2002-04-08 Univ Duke Rna aptamers and methods for identifying the same
ES2474192T3 (es) * 2001-05-25 2014-07-08 Duke University Moduladores de agentes farmacol�gicos
US20040023415A1 (en) * 2002-03-05 2004-02-05 Konstantin Sokolov Biospecific contrast agents
WO2004001065A2 (en) 2002-06-24 2003-12-31 Cornell Research Foundation, Inc. Exhaustive selection or rna aptamers against complex targets
US20070003975A1 (en) * 2003-05-02 2007-01-04 Canon Kabushiki Kaisha Structured construct and producing method therefor
EP1493810A1 (en) * 2003-06-30 2005-01-05 Gentium S.p.A. DNA-based aptamers for human cathepsin G
JP4533044B2 (ja) * 2003-08-27 2010-08-25 キヤノン株式会社 センサ
CN103045601B (zh) * 2004-04-22 2015-04-01 雷加多生物科学公司 改良的凝血因子调节物
CA2567156A1 (en) * 2004-05-17 2006-07-20 Cambrios Technology Corp. Biofabrication of transistors including field effect transistors
EP2268664B1 (en) * 2007-12-03 2017-05-24 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Doc1 compositions and methods for treating cancer
US20100018674A1 (en) * 2008-07-22 2010-01-28 Donald John Enzinna Reservoir with moveable partition for quick recovery
CN111712573B (zh) * 2018-02-12 2023-10-20 安沛治疗有限公司 针对骨硬化蛋白的适体及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217951A (en) * 1986-12-24 1993-06-08 John Lezdey Treatment of inflammation
US5290762A (en) * 1986-12-24 1994-03-01 John Lezdey Treatment of inflammation
US5612194A (en) * 1989-06-23 1997-03-18 Trustees Of The University Of Pennsylvania Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
ES2259800T3 (es) * 1990-06-11 2006-10-16 Gilead Sciences, Inc. Procedimientos de uso de ligandos de acido nucleico.
CA2104698A1 (en) * 1991-02-21 1992-08-22 John J. Toole Aptamers specific for biomolecules and methods of making
EP0587799B1 (en) * 1991-05-23 1999-07-07 Merrell Pharmaceuticals Inc. Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
US5514694A (en) * 1992-09-21 1996-05-07 Georgia Tech Research Corp Peptidyl ketoamides

Also Published As

Publication number Publication date
DE19543750A1 (de) 1997-07-03
JPH09216895A (ja) 1997-08-19
DE19543750C2 (de) 1997-10-23
DE69631409T2 (de) 2004-12-02
EP0775745A3 (en) 1999-10-13
US5780449A (en) 1998-07-14
ES2217297T3 (es) 2004-11-01
JP4257939B2 (ja) 2009-04-30
EP0775745B1 (en) 2004-01-28
EP0775745A2 (en) 1997-05-28
DE69631409D1 (de) 2004-03-04
PT775745E (pt) 2004-06-30
ATE258597T1 (de) 2004-02-15

Similar Documents

Publication Publication Date Title
DK0775745T3 (da) Cathepsin G-inhiberende aptamerer
DK0691980T3 (da) 7-deazapurinmodifiderende oligonukleotider
ATE460481T1 (de) Verfahren zur hemmung der expression eines zielgens und medikament zur therapie einer tumorerkrankung
ATE252639T1 (de) Modifizierter, das dorsalgewebe beeinflussender faktor
RU97120584A (ru) Ингибитор активности il-6
DE69934010D1 (de) Zusammensetzungen zur behandlung von chlamydiale assozierten krankheiten
NO893054D0 (no) Fremgangsmaate for utdypning av nukleotidsekvenser.
FI946201A (fi) Itsestabiloidut oligonukleotidit terapeuttisina aineina
ITTO950104A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
DE69328025T2 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
DE60042585D1 (de) 3-Aza-6,8-dioxabicycloÄ3.2.1Üoctane und Analoga sowie diese enthaltende kombinatorische Bibliotheken
HUP9802423A2 (hu) Hiperproliferatív megbetegedések kombinált gyógyászati kezelése
PT804465E (pt) Novos inibidores da elastase
NO980296D0 (no) Forbedrede terapeutiske midler
ATE160354T1 (de) Oligonukleotide mit anti-cytomegalovirus wirkung
PT1137438E (pt) Preparado com espectro terapeutico melhorado, contendo inibidores da sintese de nucleotidos
ITTO940379A1 (it) Sequenze specifiche per il dna umano.
TR199700863A3 (tr) Paklitaksel hazirlama prosesi.
ITBO970602A0 (it) Apparecchiatura per trattamento di dialisi.
NL1001157A1 (nl) Zuiveringsinstallatie.
NO20022799D0 (no) Antisens oligonukleotider
IT1284413B1 (it) Impianto trattamento r.s.u.
ITSR950001A0 (it) Scacchiera per gioco s.b.a.n.
HUT37105A (en) Device for cleaning sewage